Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Microbiol Methods ; 184: 106201, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33713725

RESUMEN

Enteropathogenic E. coli (EPEC) causes intestinal infections leading to severe diarrhea. EPEC attaches to the host cell causing lesions to the intestinal epithelium coupled with the effacement of microvilli. In the process, actin accumulates into a pedestal-like structure under bacterial microcolonies. We designed an automated fluorescence microscopy-based screening method for discovering compounds capable of inhibiting EPEC adhesion and virulence using aurodox, a type three secretion system (T3SS) inhibitor, as a positive control. The screening assay employs an EPEC strain (2348/69) expressing a fluorescent protein and actin staining for monitoring the bacteria and their pedestals respectively, analyzing these with a custom image analysis pipeline. The assay allows for the discovery of compounds capable of preventing the formation of pathogenic actin rearrangements. These compounds may be interfering with virulence-related molecular pathways relevant for developing antivirulence leads.


Asunto(s)
Antibacterianos/farmacología , Automatización/métodos , Adhesión Bacteriana/efectos de los fármacos , Evaluación Preclínica de Medicamentos/métodos , Escherichia coli Enteropatógena/efectos de los fármacos , Escherichia coli Enteropatógena/fisiología , Microscopía Fluorescente/métodos , Escherichia coli Enteropatógena/genética , Escherichia coli Enteropatógena/patogenicidad , Infecciones por Escherichia coli/microbiología , Proteínas de Escherichia coli/antagonistas & inhibidores , Proteínas de Escherichia coli/metabolismo , Humanos , Sistemas de Secreción Tipo III/antagonistas & inhibidores , Sistemas de Secreción Tipo III/metabolismo , Virulencia/efectos de los fármacos
2.
Drug Discov Ther ; 13(6): 335-342, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31956232

RESUMEN

Foodborne diseases have become a worldwide problem that threatens public health and welfare. Enteropathogenic Escherichia coli (EPEC) is one of major pathogens of moderate to severe diarrhea. The increased prevalence of EPEC strains that produce extended spectrum ß-lactamase (ESBL) has deepened the problem. The fruit of Lonicera caerulea var. emphyllocalyx (LCE) has been used as a traditional food preservative and medicine in northern temperate zones such as Hokkaido Island, Japan. In this study, we investigated the antibacterial effect of LCE fruit extract (LCEE) against EPEC. The antibacterial activities of LCEE were examined by bacterial growth, time-kill curve, soft-agar motility, electron microscopy, and 96 well-microplate biofilm assays. We also investigated the bacterial mRNA expression of biofilm-associated genes (fliC, csgA, and fimA) by quantitative real-time PCR assays. LCEE was found to suppress the growth, time-kill curve, and spread of EPEC. It also reduced the biofilm formation in a dose-dependent manner. Morphological analysis using transmission and scanning electron microscopy revealed that LCEE diminished the function of flagella resulting in reduced motility and biofilm formation. The mRNA expression of all three biofilm associated genes was downregulated under LCEE treatment. Extracts of the fruit of LCE inhibit the motility and biofilm formation of EPEC as a result of the inhibition of flagella development and function. We propose LCEE as a therapeutic candidate for the effective therapy of EPEC-associated infectious diseases.


Asunto(s)
Antibacterianos/farmacología , Escherichia coli Enteropatógena/fisiología , Lonicera/química , Metanol/farmacología , Antibacterianos/química , Biopelículas/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Escherichia coli Enteropatógena/efectos de los fármacos , Proteínas de Escherichia coli/genética , Proteínas Fimbrias/genética , Flagelos/efectos de los fármacos , Flagelos/fisiología , Flagelina/genética , Frutas/química , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Metanol/química , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/química , Extractos Vegetales/farmacología
3.
Appl Environ Microbiol ; 81(11): 3766-74, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25819956

RESUMEN

Zinc supplements are an effective clinical treatment for infantile diarrheal disease caused by enteric pathogens. Previous studies demonstrated that zinc acts on enteropathogenic Escherichia coli (EPEC) bacteria directly to suppress several virulence-related genes at a concentration that can be achieved by oral delivery of dietary zinc supplements. Our in vitro studies showed that a micromolar concentration of zinc induced the envelope stress response and suppressed virulence in EPEC, providing a possible mechanistic explanation for zinc's therapeutic action. In this report, we investigated the molecular and physiological changes in EPEC induced by zinc. We found that micromolar concentrations of zinc reduced the bacterial growth rate without affecting viability. We observed increased membrane permeability caused by zinc. Zinc upregulated the RpoE-dependent envelope stress response pathway and suppressed EPEC virulence gene expression. RpoE alone was sufficient to inhibit virulence factor expression and to attenuate attaching and effacing lesion formation on human host cells. By mutational analysis we demonstrate that the DNA-binding motif of RpoE is necessary for suppression of the LEE1, but not the LEE4, operon. Predictably, inhibition of the RpoE-mediated envelope stress response in combination with micromolar concentrations of zinc reduced EPEC viability. In conclusion, zinc induces the RpoE and stress response pathways in EPEC, and the alternate sigma factor RpoE downregulates EPEC LEE and non-LEE virulence genes by multiple mechanisms.


Asunto(s)
Escherichia coli Enteropatógena/efectos de los fármacos , Escherichia coli Enteropatógena/genética , Regulación Bacteriana de la Expresión Génica , Factor sigma/metabolismo , Estrés Fisiológico , Zinc/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Escherichia coli Enteropatógena/crecimiento & desarrollo , Escherichia coli Enteropatógena/fisiología , Viabilidad Microbiana/efectos de los fármacos , Virulencia/efectos de los fármacos
4.
São Paulo; s.n; 16 abr. 2009. 134 p. graf, tab, ilus.
Tesis en Portugués | LILACS | ID: lil-525239

RESUMEN

A diarréia é um importante problema de saúde pública no mundo inteiro e a Escherichía coli é um dos mais freqüentes microorganismos causadores desta doença. A Escherichia coli enteropatogênica (EPEC), um dos principais agentes etiológicos das diarréias infantis no nosso país, é genética e fenotipicamente relacionada com a E. colí enterohemorrágica (EHEC) que além de provocar diarréia é responsável por complicações como síndrome hemolítica urêmica (HUS) e colite hemorrágica (HC). Embora a EHEC seja considerada emergente pela OMS, no Brasil poucos casos de complicações como HUS e HC foram reportados. O mecanismo de patogenicidade comum entre EPEC e EHEC é conhecido como a lesão "attaching and effacing" nos microvilos do enterócito. Esta lesão é mediada por um conjunto de fatores de virulência, dentre eles a intimina. A intimina é uma proteína de membrana externa, responsável pelo íntimo contato da bactéria com o enterócito, possui uma região N-terminal que é altamente conservada e uma região C-terminal que é variável. De acordo com a região variável, existem vários subtipos de intimina, dentre eles as intiminas , α, β e γ...


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Anticuerpos/genética , Anticuerpos/inmunología , Diarrea/genética , Diarrea/inmunología , Escherichia coli Enteropatógena/fisiología , Escherichia coli Enteropatógena/inmunología , Factores de Virulencia/genética , Factores de Virulencia/inmunología , Infecciones por Escherichia coli/inmunología , Calostro , Ensayo de Inmunoadsorción Enzimática , Métodos Analíticos de la Preparación de la Muestra , Suero , Interpretación Estadística de Datos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA